Terms: = Thyroid cancer AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Prognosis
7 results:
1. A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer.
Han PZ; Ye WD; Yu PC; Tan LC; Shi X; Chen XF; He C; Hu JQ; Wei WJ; Lu ZW; Qu N; Wang Y; Ji QH; Ji DM; Wang YL
JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38478516
[TBL] [Abstract] [Full Text] [Related]
2. Primary thyroid lymphoma: a case series.
Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
[TBL] [Abstract] [Full Text] [Related]
3. B cells and tertiary lymphoid structures are associated with survival in papillary thyroid cancer.
Li YY; Li SJ; Liu MC; Chen Z; Li L; Shen F; Liu QZ; Xu B; Lian ZX
J Endocrinol Invest; 2023 Nov; 46(11):2247-2256. PubMed ID: 37004696
[TBL] [Abstract] [Full Text] [Related]
4. CD20
Wu Z; Zhou J; Xiao Y; Ming J; Zhou J; Dong F; Zhou X; Xu Z; Zhao X; Lei P; Huang T
Front Immunol; 2022; 13():865596. PubMed ID: 35634306
[TBL] [Abstract] [Full Text] [Related]
5. Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma.
Olszewski AJ; Winer ES; Castillo JJ
Leuk Res; 2014 Aug; 38(8):866-73. PubMed ID: 24837081
[TBL] [Abstract] [Full Text] [Related]
6. [Malignant lymphoma of the thyroid].
Ohye H; Fukata S; Hirokawa M
Nihon Rinsho; 2007 Nov; 65(11):2092-8. PubMed ID: 18018576
[TBL] [Abstract] [Full Text] [Related]
7. [Malignant lymphoma of the thyroid gland].
Caparević Z; Stojanović D; Bojković G; Lalosević D; Stojanović M
Med Pregl; 2002; 55(11-12):485-9. PubMed ID: 12712891
[TBL] [Abstract] [Full Text] [Related]
